• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性髓系白血病和骨髓增生异常综合征中CDKN1B和ETV6的缺失,且无12p异常的细胞遗传学证据。

Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities.

作者信息

Andreasson P, Johansson B, Arheden K, Billström R, Mitelman F, Höglund M

机构信息

Department of Clinical Genetics, Lund University Hospital, Sweden.

出版信息

Genes Chromosomes Cancer. 1997 Jun;19(2):77-83. doi: 10.1002/(sici)1098-2264(199706)19:2<77::aid-gcc2>3.0.co;2-x.

DOI:10.1002/(sici)1098-2264(199706)19:2<77::aid-gcc2>3.0.co;2-x
PMID:9171997
Abstract

Seventy-nine acute myeloid leukemias (AML) and myelodysplastic syndromes without cytogenetic evidence of 12p aberrations were investigated by fluorescence in situ hybridization with probes for ETV6 and CDKN1B (previously called TEL and KIP1, respectively) to ascertain whether abnormalities of these genes are frequently undetected by standard chromosome banding analyses and, if so, whether they are associated with specific karyotypic patterns and morphologic features. One of sixty cytogenetically aberrant myeloid malignancies, an AML with a complex karyotype including del(5q) and del(20q), showed a hemizygous interstitial deletion of the ETV6 and CDKN1B loci. No concomitant rearrangement of the other ETV6 allele was detected. Two of nineteen cytogenetically normal AML displayed a hemizygous interstitial deletion involving CDKN1B, but not ETV6. Thus, cryptic deletions of these genes seem to be rare in cytogenetically abnormal myeloid malignancies without 12p aberrations (2%), whereas they may be more frequent in karyotypically normal AML (10%). Furthermore, the present findings show that the deletions may be narrow, not including the ETV6 gene, and indirectly suggest that CDKN1B, or a closely located genomic segment, is the target of 12p deletions.

摘要

对79例急性髓系白血病(AML)和骨髓增生异常综合征进行研究,这些病例在细胞遗传学上未发现12p畸变证据。通过使用ETV6和CDKN1B(以前分别称为TEL和KIP1)的探针进行荧光原位杂交,以确定这些基因的异常是否经常在标准染色体带分析中未被检测到,如果是,它们是否与特定的核型模式和形态学特征相关。在60例细胞遗传学异常的髓系恶性肿瘤中,有1例AML具有包括del(5q)和del(20q)的复杂核型,显示ETV6和CDKN1B位点的半合子间质缺失。未检测到另一个ETV6等位基因的伴随重排。在19例细胞遗传学正常的AML中,有2例显示涉及CDKN1B而非ETV6的半合子间质缺失。因此,在细胞遗传学异常且无12p畸变的髓系恶性肿瘤中,这些基因的隐匿性缺失似乎很少见(2%),而在核型正常的AML中可能更常见(10%)。此外,目前的研究结果表明,这些缺失可能很窄,不包括ETV6基因,并间接表明CDKN1B或紧密定位的基因组片段是12p缺失的靶点。

相似文献

1
Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities.急性髓系白血病和骨髓增生异常综合征中CDKN1B和ETV6的缺失,且无12p异常的细胞遗传学证据。
Genes Chromosomes Cancer. 1997 Jun;19(2):77-83. doi: 10.1002/(sici)1098-2264(199706)19:2<77::aid-gcc2>3.0.co;2-x.
2
A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).由ETV6和CDKN1B侧翼的12p12.3染色体区域的物理、转录本和缺失图谱:两名半合子del(12p)白血病患者中LRP6 CpG岛的高甲基化。
Genomics. 1999 Feb 15;56(1):40-50. doi: 10.1006/geno.1998.5685.
3
TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.TEL和KIP1确定了造血系统恶性肿瘤中12p13上最小的缺失区域。
Blood. 1995 Aug 15;86(4):1525-33.
4
Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements.血液系统恶性肿瘤的荧光原位杂交分析显示,存在频繁的细胞遗传学未识别的12号染色体短臂重排。
Leukemia. 1998 Mar;12(3):390-400. doi: 10.1038/sj.leu.2400929.
5
Abnormalities of the ETV6 gene occur in the majority of patients with aberrations of the short arm of chromosome 12: a combined PCR and Southern blotting analysis.12号染色体短臂畸变的大多数患者中存在ETV6基因异常:聚合酶链反应和Southern印迹联合分析
Leukemia. 1998 Jul;12(7):1099-106. doi: 10.1038/sj.leu.2401070.
6
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.急性髓系白血病伴复杂核型患者中ETV6和CDKN1B的单倍剂量不足
BMC Genomics. 2014 Sep 11;15(1):784. doi: 10.1186/1471-2164-15-784.
7
CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.CDKN1B 编码细胞周期蛋白依赖性激酶抑制剂 1B(p27),位于髓系恶性肿瘤中 12p 异常最小缺失区域,其低表达是急性髓系白血病的有利预后标志物。
Haematologica. 2011 Jun;96(6):829-36. doi: 10.3324/haematol.2010.035584. Epub 2011 Mar 21.
8
Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2.
Blood. 1996 Jan 1;87(1):324-30.
9
12p12-13 deletion in prostate tumors and quantitative expression of CDKN1B and ETV6 candidate genes.
Genes Chromosomes Cancer. 2001 Jun;31(2):199-200. doi: 10.1002/gcc.1135.
10
ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia.ETV6是儿童急性淋巴细胞白血病t(12;21)中12号染色体短臂缺失的靶点。
Leukemia. 1997 Sep;11(9):1459-64. doi: 10.1038/sj.leu.2400798.

引用本文的文献

1
Genetic Predisposition to Hematologic Malignancies.血液系统恶性肿瘤的遗传易感性
Cold Spring Harb Perspect Med. 2025 Feb 10. doi: 10.1101/cshperspect.a041585.
2
SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances.白血病中的SET-CAN/NUP214融合基因:一般特征与临床进展
Front Oncol. 2023 Oct 16;13:1269531. doi: 10.3389/fonc.2023.1269531. eCollection 2023.
3
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.急性髓系白血病伴复杂核型患者中ETV6和CDKN1B的单倍剂量不足
BMC Genomics. 2014 Sep 11;15(1):784. doi: 10.1186/1471-2164-15-784.
4
Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.淋巴瘤患者自体造血干细胞移植后与治疗相关的髓系肿瘤
Cancer Biol Ther. 2013 Dec;14(12):1077-88. doi: 10.4161/cbt.26342. Epub 2013 Oct 18.
5
Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase.对 80 例处于慢性或急性期的骨髓纤维化患者的 23 个基因进行阵列比较基因组杂交和测序。
Haematologica. 2014 Jan;99(1):37-45. doi: 10.3324/haematol.2013.091454. Epub 2013 Aug 30.
6
A novel cytogenetic abnormality t(7;8)(p11.2:q11.2) and a four-way Philadelphia translocation in an imatinib mesylate-resistant chronic myeloid leukemia patient.一名甲磺酸伊马替尼耐药的慢性髓性白血病患者中出现一种新的细胞遗传学异常t(7;8)(p11.2:q11.2)和一种复杂的费城染色体易位。
Oncol Lett. 2013 Feb;5(2):617-620. doi: 10.3892/ol.2012.1037. Epub 2012 Nov 21.
7
CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.CDKN1B 编码细胞周期蛋白依赖性激酶抑制剂 1B(p27),位于髓系恶性肿瘤中 12p 异常最小缺失区域,其低表达是急性髓系白血病的有利预后标志物。
Haematologica. 2011 Jun;96(6):829-36. doi: 10.3324/haematol.2010.035584. Epub 2011 Mar 21.
8
Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes.采用基于微阵列的比较基因组杂交技术评估骨髓增生异常/骨髓增殖性综合征中的核型精确性。
Mol Cytogenet. 2010 Nov 15;3:23. doi: 10.1186/1755-8166-3-23.
9
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype.间期细胞遗传学检测正常核型骨髓增生异常综合征隐匿性染色体病变的临床重要性。
Leukemia. 2001 Dec;15(12):1841-7. doi: 10.1038/sj.leu.2402293.
10
Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.TEL和AML-1都为t(12;21)融合蛋白提供抑制结构域。
Mol Cell Biol. 1999 Oct;19(10):6566-74. doi: 10.1128/MCB.19.10.6566.